D.NarayanM.AndersonE
Finally, following acute absolute alcohol intragastric administration, BPC 157 therapy attenuated/eliminated the alcohol-occlusion/occlusion-like syndrome as a whole, major vascular and multiorgan failure [56], as described above [40,41,42,43,47,48,49,50,51,52,53,54,55,56]
GIP/GLP-1 SGLT2DPP4GLP-1 GIP/GLP-1 GIP/GLP-1 GIP/GLP-1 GIPglucose-dependent insulinotropic polypeptide: GLP-1glucagon-like peptide 1: -1 GLP-1 5mg 1.0mgSURPASS-25mg1mg-7.6kg15mg-11.2kg SURPASS-21mg5mg/40HbA1c2%HbA1c2% N Engl J Med 385(6):503-15,2021. 2SRPUSS J-monoHbA1c7.067HbA1c 7.094 GIPGLP-1 111 GIP/GLP-12023 2022 SURPASS-J-mono GLP-1 / 9 FORTUNE DREAM
We interrogate the research each camp leans on, talk about where it holds up and where it falls apart when applied to intermediate to advanced trainees
By the time the regulator and the clinical community arrive, the product has been in the market for five years and the user base has its own folk pharmacology that no published paper is going to displace